PARP Inhibitors Market Size, Share, Growth, Trends, Analysis and Forecast

1

PARP Inhibitors Market Revenue, Key Players,
Profit, Growth Factors, Regions And Applications,
Industry Forecast By 2026 FMI

• May 2021

Report Id     REP-GB-3197Published On  
2020-02-12Category Healthcare, Pharmaceuticals
Medical Devices
2
AboutFuture Market Insights
Future Market Insights (FMI) is a premier
provider of syndicated research reports, custom
research reports, and consulting services. We
deliver a complete packaged solution, which
combines current market intelligence, statistical
anecdotes, technology inputs, valuable growth
insights, aerial view of the competitive
framework, and future market trends. We provide
research services at a global as well as regional
level key regions include GCC, ASEAN,
and BRIC. Our offerings cover a broad spectrum of
industries including Chemicals, Materials,
Energy, Technology, Healthcare, and Retail. We
have a global presence with delivery centers
across India specializing in providing global
research reports and country research reports.
FMI is headquartered out of London, U.K., with a
state-of-the-art delivery center located in Pune,
India. We combine our knowledge and learning from
every corner of the world to distill it to one
thing the perfect solution for our client.
Research Capabilities
Sector Coverage

• Customized Research
• Syndicated Research
• Investment Research
• Social Media Research

• Automotive and Transportation
• Electronics, Semiconductor, and ICT
• Retail and Consumer Products
• Industrial Automation and Equipment

• Chemicals Materials
• Food and Beverages
• Services and Utilities
• Energy, Mining, Oil, and Gas

Subscription Information

For detailed subscription information please
contact Hari. T (Sr. Manager - Global Business
Development) T 44 (0) 20 7692 8790 D 44
20 3287 4268 Email hari.t_at_futuremarketinsights.co
m
3
Research Methodology (1/2)

• Systematic Research Approach

In-depth secondary research is used to ascertain overall market size, top industry players, top products, industry associations, etc.
FMI formulates a detailed discussion guide to conduct expert and industry interviews
FMI develops a list of industry players (manufacturers), distributors, retailers and industry experts
FMI conducts interviews with industry experts, industry players, distributors and retailers
Data is validated by triangulation method, wherein secondary, primary and FMI analysis contribute to the final data
Data is scrutinized using MS-Excel to obtain qualitative and quantitative insights about the industry
FMI delivers industry insights and information in the required format (PDF)

• Identifying key opinion leaders
• Questionnaire design
• In-depth interviews
• Coverage across value chain

• Key industry experts
• Channel study
• Developments
• Market dynamics
• Products
• Conclusions

SOLUTION

• Market participants
• Key strengths
• Product portfolio
• Mapping as per value chain
• Key focus segments

Primary Research
Secondary Research
Paid Publications

• Linkedin
• Zoominfo
• Salesforce
• Avention

• Factiva
• GBI
• Genios
• Meltwater

• Company websites
• Company annual reports
• White papers
• Financial reports

includes sources of databases
4
PARP Inhibitors Market Analysis

• The global poly ADP ribose polymerase (PARP)
  inhibitors market is poised for an exponential
  growth at a CAGR of 15 during the forecast
  period (2019-2026). Strong demand from the
  flourishing pharmaceutical industries a key
  contributor for this growth projection. PARP
  inhibitors have gained noteworthy momentum owing
  to increased awareness about efficacy in terms of
  treating different types of cancer.
• The unique ability of PARP inhibitors to improve
  progression-free survival in ovarian and breast
  cancer patients is expected to generate extensive
  traction for the market, thereby propelling the
  growth of the global PARP inhibitors market over
  the forecast period, forecasts the FMI report.
• Request sample of this report at https//www.futur
  emarketinsights.com/reports/sample/rep-gb-3197
• Key Takeaways of PARP Inhibitors Market Study
• Olaparib is projected to dominate the global PARP
  inhibitors market owing to its applications in
  ovarian cancer, breast cancer, and pancreatic
  cancer.
• A number of PARP inhibitors are up for imminent
  approval owing to a new drug application process.

5
PARP Inhibitors Market Analysis

• PARP inhibitors are rapidly gaining traction as a
  new care standard of ovarian cancer treatment
  following platinum chemotherapy.
• North America and Europe are projected to remain
  the dominant regional PARP inhibitors markets
  owing to better access to new technology and
  reimbursement policies.
• Centralizing access to virtual and physical care
  with the aid of startups, research institutes and
  government bodies will play a key role in role
  for the future.
• PARP Inhibitors Market Top Growth Drivers
• The rising burden of the different cancer types
  is a key driver behind the demand for PARP
  inhibitors.
• The superior efficacy of PARP inhibitors over
  that of other cancer treatments is expected to
  drive revenue generation in the forecast period.
• Faster approval of PARP inhibitor drugs are also
  anticipated to drive adoption rates, as demand
  rises.
• PARP Inhibitors Market Key Restraints
• High costs related to clinical trials, insurance
  coverage, and testing for drug-drug interactions
  is a key restraint, particularly for emerging
  players.
• The nascent nature of the PARP inhibitors market
  also builds the risk of such dosages not being
  included in select electronic records.

6
PARP Inhibitors Market Analysis
Competitive Landscape Some of the key market
players profiled in the report include, but are
not limited to TESARO Inc., AbbVie Inc., Pfizer
Inc., AstraZeneca, CLOVIS ONCOLOGY. Mergers and
acquisitions are the key developmental strategies
being adopted by leading market players, as the
market is projected to remain in a consolidated
stage through the forecast period. Such moves
will enable manufacturers to widen their scope of
regional product offerings. For instance, TESARO
Inc., was acquired by Glaxo Smith Kline plc which
allowed the latter to expand its product
portfolio with the inclusion of Zejula
(Niraparib) PARP inhibitor. Schedule a meeting
with expert analysts for detailed
insights https//www.futuremarketinsights.com/ask-
the-analyst/rep-gb-3197
7
PARP Inhibitors Market Analysis

• More About the Report
• The 200-page study offers an in-depth market
  forecast and analysis on PARP inhibitors market.
  The major categories encompassed by the report
  include drug (olaparib, niraparib, rucaparib, and
  talazoparib), indication (ovarian cancer, breast
  cancer, prostate cancer, and pancreatic cancer),
  distribution channel (hospital pharmacies, retail
  pharmacies, and online pharmacies) across seven
  regions (Middle East Africa, Oceania, Europe,
  Latin America, South Asia, East Asia, North
  America).
• Explore Extensive Coverage of FMIs Healthcare,
  Pharmaceuticals and Medical Devices Landscape
• Liquid Biopsy Market FMIs comprehensive
  analysis on the global liquid biopsy market helps
  stakeholders identify challenges and
  opportunities. The study covers key regions,
  competitive landscape, winning imperatives, and
  key recommendations.
• Narcolepsy Treatment Market Get actionable
  insights on the global narcolepsy treatment
  market covering important market dynamics,
  current and historical growth parameters, and
  future growth prospects for 2018-2028.
• Protein Expression Technology Market Find a
  deep-dive analysis of the global protein
  expression technology market encompassing market
  performance parameters, key trends, revenue
  forecast, and value projection along with market
  share analysis of key players.

8
To know more about us, please visit our website
www.futuremarketinsights.com For sales queries
or new topics email us on sales_at_futuremarketinsi
ghts.com For media queries, contact the press
office at press_at_futuremarketinsights.com For
other queries contactHari. T (Sr. Manager -
Global Business Development) Future Market
Insights 3rd Floor,207 Regent Street, London
W1B 3HH T 44 20 7692 8790 D 44 20 3287
4268 Email hari.t_at_futuremarketinsights.com
Thank You
Future Market Insights Global Consulting
Private Limited (FMI)